Maternal and perinatal outcome in Rh negative mothers

Mamta Sharma; Kiran Raigar; Jyoti Sisodiya

doi:10.18203/2320-1770.ijrcog20233621

Authors

Mamta Sharma Department of Obstetrics and Gynaecology, J. K. Lone Hospital, Kota, Rajasthan, India
Kiran Raigar Department of Obstetrics and Gynaecology, J. K. Lone Hospital, Kota, Rajasthan, India
Jyoti Sisodiya Department of Obstetrics and Gynaecology, J. K. Lone Hospital, Kota, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20233621

Keywords:

Erythroblastosis fetalis, Heterozygous, Hyperbilirubinemia, Isoimmunization

Abstract

Background: Incidence of Rh negativity in India is 5-10%. Rh negative pregnancy poses a risk only when there is incompatible mating, leading to antigen-antibody reaction, and hemolysis. However, it can be prevented by adequate measures.

Methods: This prospective observational study conducted at Government Medical College hospital and J.K. Lon hospital Kota 100 women with Rh negative blood group admitted for delivery were enrolled.

Results: Mean age of study participants was 26.87 years with SD of 3.62 years and the prevalence of Rh-negative pregnancy was around 2.9. Rhesus isoimmunization is a preventable cause of fetal morbidity and mortality.

Conclusions: Rhesus isoimmunization is a preventable cause of fetal morbidity and mortality. Routine antenatal screening and timely management with intrauterine transfusion are lifesaving method which should be incorporated in daily obstetrics practice.

Metrics

Metrics Loading ...

References

Shradha, Moitra B, Kumari A, Sahay PB. Obstetrical and Perinatal Outcome in Rhesus Antigen Negative Pregnancy. Int J Sci Stud. 2016;3(11):124-9.

Committee on Practice Bulletins Obstetrics ("Practice Bulletin No. 181: Prevention of Rh D Alloimmunization". Am J Obstet Gynecol. 2017;130(2):e57-7.

Landsteiner K, Weiner AS. An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Roc Soc Exp Biol Med. 1940;43:223.

Levine P. Serological factor as possible cause in spontaneous abortion. In: Rhesus haemolytic disease. Springer, Dordrechi. 1943;75-7.

Dean L. Blood Groups and Red Cell Antigens. Chapter 7. Bethesda (MD): National Center for Biotechnology Information (US). 2005.

The American Society of Health-System Pharmacists. "Rho (D) Immune Globulin". Available at: https://www.d rugs.com/monograph/rho-d-immune-glob ulin.html). Accessed on 09 September 2023.

British National Formulary: BNF 69 (69 edition). British Medical Association. 2015;871.

Cunningham F, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, Spong CY, editors. Williams Obstetrics. 25th Edition. McGraw Hill. 2018.

Sreelatha S, Ambastha V, Chaitra S, Satish D, Sandeep. Maternal and neonatal outcome in rhesus positive women in a tertiary care center. MOJ Womens Health. 2017;5(2):202-4.

Eleje GU, llika CP, Ezeama CO. Feto maternal outcomes of women with rhesus iso immunization in a Nigerian tertiary health care institution. J Preg Neonatal Med. 2017;1(1):21-7.

Alakanand, Das M, Paul M. Rhesus Negative Mother and Perinatal outcome. Sch Int J Obstet Gynec. 2019;2(11):284.

Preethi IS, Sravani K, Anuradha K. Rh negative complicating pregnancy Prevalance, Maternal and Foetal Outcome inn GGH Guntur. IOSR J Dent Med Sci. 2019;19:12-5.

Mondal B, Maiti S, Biswas BK, Ghosh D, Paul S. Prevalence of hemoglobinopathy, ABO and rhesus blood groups in rural areas of West Bengal, India. J Res Med Sci. 2012;17(8):772-6.

Agarwal S, Seema, Sharma S. Rh negative pregnancy: maternal and perinatal outcome in Bundelkhand region. J Evol Med Dent Sci. 2016;5(71):5165-8.

Shradha, Moitra B, Kumari A, Sahay PB. Obstetrical and Perinatal Outcome in Rhesus Antigen Negative Pregnancy. Int J Sci Stud. 2016;3(11):124-9.

Okeke TC, Ocheni S, Nwagha UI. The prevalence of rhesus negativity among pregnant women in Enugu, southeast Nigeria. Niger J Clin Pract. 2012;15(4):400-2.

Chintada H, Bai B. Maternal and perinatal outcome in rhesus antigen pregnancy. IAIM. 2020;7(11):8-14.